The present disclosure relates to a compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.
